Potential mouse models of coronavirus-related immune injury

Front Immunol. 2022 Sep 2:13:943783. doi: 10.3389/fimmu.2022.943783. eCollection 2022.

Abstract

Basic research for prevention and treatment of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues worldwide. In particular, multiple newly reported cases of autoimmune-related diseases after COVID-19 require further research on coronavirus-related immune injury. However, owing to the strong infectivity of SARS-CoV-2 and the high mortality rate, it is difficult to perform relevant research in humans. Here, we reviewed animal models, specifically mice with coronavirus-related immune disorders and immune damage, considering aspects of coronavirus replacement, viral modification, spike protein, and gene fragments. The evaluation of mouse models of coronavirus-related immune injury may help establish a standardised animal model that could be employed in various areas of research, such as disease occurrence and development processes, vaccine effectiveness assessment, and treatments for coronavirus-related immune disorders. COVID-19 is a complex disease and animal models cannot comprehensively summarise the disease process. The application of genetic technology may change this status.

Keywords: COVID-19; SARS-CoV-2; coronavirus; immune injury; mouse model.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COVID-19*
  • Disease Models, Animal
  • Humans
  • Mice
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus*

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2